A single nucleotide polymorphism in the TGF-β1 gene (rs1982073 C>T) may contribute to increased risks of bone fracture, osteoporosis, and osteoarthritis: a meta-analysis

详细信息    查看全文

• 作者：Yu Cong ; Jiang-Ying Ru ; Ni-Rong Bao ; Ting Guo ; Jian-Ning Zhao
• 关键词：Bone fracture ; Meta ; analysis ; Osteoarthritis ; Osteoporosis ; Single nucleotide polymorphism ; Transforming growth factor ; β1
• 刊名：Clinical Rheumatology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：35
• 期：4
• 页码：973-985
• 全文大小：626 KB
• 参考文献：1.Shibuya N, Davis ML, Jupiter DC (2014) Epidemiology of foot and ankle fractures in the United States: an analysis of the national trauma data bank (2007 to 2011). J Foot Ankle Surg 53(5):606–608CrossRef PubMed
  2.Wang XF, Seeman E (2012) Epidemiology and structural basis of racial differences in fragility fractures in Chinese and Caucasians. Osteoporos Int 23(2):411–422CrossRef PubMed
  3.Lanza LL, McQuay LJ, Rothman KJ, Bone HG, Kaunitz AM, Harel Z, Ataher Q, Ross D, Arena PL, Wolter KD (2013) Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture. Obstet Gynecol 121(3):593–600CrossRef PubMed
  4.Pressley JC, Kendig TD, Frencher SK, Barlow B, Quitel L, Waqar F (2011) Epidemiology of bone fracture across the age span in blacks and whites. J Trauma 71(5 Suppl 2):S541–S548CrossRef PubMed PubMedCentral
  5.Henrotin Y (2011) Muscle: a source of progenitor cells for bone fracture healing. BMC Med 9:136CrossRef PubMed PubMedCentral
  6.Kawate H, Takayanagi R (2011) Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Clin Interv Aging 6:151–160CrossRef PubMed PubMedCentral
  7.Banu J (2013) Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther 7:849–860CrossRef PubMed PubMedCentral
  8.Lambert JK, Zaidi M, Mechanick JI (2011) Male osteoporosis: epidemiology and the pathogenesis of aging bones. Curr Osteoporos Rep 9(4):229–236CrossRef PubMed
  9.Guillemin F, Rat AC, Mazieres B, Pouchot J, Fautrel B, Euller-Ziegler L, Fardellone P, Morvan J, Roux CH, Verrouil E, Saraux A, Coste J, Osteoarthritis G (2011) Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. Osteoarthritis Cartilage 19(11):1314–1322CrossRef PubMed
  10.Lluch Girbes E, Nijs J, Torres-Cueco R, Lopez Cubas C (2013) Pain treatment for patients with osteoarthritis and central sensitization. Phys Ther 93(6):842–851CrossRef PubMed
  11.Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E (2011) The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 19(11):1270–1285CrossRef PubMed
  12.Raje M, Botre C, Ashma R (2013) Genetic epidemiology of osteoporosis across four microsatellite markers near the VDR gene. Int J Mol Epidemiol Genet 4(2):101–108PubMed PubMedCentral
  13.Inanir A, Yigit S, Tural S, Cecen O, Yildirim E (2013) MTHFR gene C677T mutation and ACE gene I/D polymorphism in Turkish patients with osteoarthritis. Dis Markers 34(1):17–22CrossRef PubMed PubMedCentral
  14.de Gorter DJ, van Dinther M, Korchynskyi O, ten Dijke P (2011) Biphasic effects of transforming growth factor beta on bone morphogenetic protein-induced osteoblast differentiation. J Bone Miner Res 26(6):1178–1187CrossRef PubMed
  15.Toti P, Sbordone C, Martuscelli R, Califano L, Ramaglia L, Sbordone L (2013) Gene clustering analysis in human osteoporosis disease and modifications of the jawbone. Arch Oral Biol 58(8):912–929CrossRef PubMed
  16.Remst DF, Blom AB, Vitters EL, Bank RA, van den Berg WB, Blaney Davidson EN, van der Kraan PM (2014) Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factor beta-responsive genes in osteoarthritis-related fibrosis. Arthritis Rheumatol 66(3):647–656CrossRef PubMed
  17.Quan J, Elhousiny M, Johnson NW, Gao J (2013) Transforming growth factor-beta1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts. Clin Exp Metastasis 30(5):659–670CrossRef PubMed PubMedCentral
  18.Brophy TM, Coller BS, Ahamed J (2013) Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor beta1 (TGF-beta1) activation. J Biol Chem 288(15):10628–10639CrossRef PubMed PubMedCentral
  19.Campos-Xavier B, Saraiva JM, Savarirayan R, Verloes A, Feingold J, Faivre L, Munnich A, Le Merrer M, Cormier-Daire V (2001) Phenotypic variability at the TGF-beta1 locus in Camurati–Engelmann disease. Hum Genet 109(6):653–658CrossRef PubMed
  20.Park J, Lee J, Kang W, Chang S, Shin EC, Choi C (2013) TGF-beta1 and hypoxia-dependent expression of MKP-1 leads tumor resistance to death receptor-mediated cell death. Cell Death Dis 4:e521CrossRef PubMed PubMedCentral
  21.Ochiai H, Okada S, Saito A, Hoshi K, Yamashita H, Takato T, Azuma T (2012) Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-beta1 (TGF-beta1) administration suppresses osteoblast differentiation. J Biol Chem 287(27):22654–22661CrossRef PubMed PubMedCentral
  22.Kaiser G, Thomas A, Kottstorfer J, Kecht M, Sarahrudi K (2012) Is the expression of Transforming Growth Factor-Beta1 after fracture of long bones solely influenced by the healing process? Int Orthop 36(10):2173–2179CrossRef PubMed PubMedCentral
  23.Muthuri SG, Doherty S, Zhang W, Maciewicz RA, Muir KR, Doherty M (2013) Gene–environment interaction between body mass index and transforming growth factor beta 1 (TGFbeta1) gene in knee and hip osteoarthritis. Arthritis Res Ther 15(2):R52CrossRef PubMed PubMedCentral
  24.Mori S, Fuku N, Chiba Y, Tokimura F, Hosoi T, Kimbara Y, Tamura Y, Araki A, Tanaka M, Ito H (2010) Cooperative effect of serum 25-hydroxyvitamin D concentration and a polymorphism of transforming growth factor-beta1 gene on the prevalence of vertebral fractures in postmenopausal osteoporosis. J Bone Miner Metab 28(4):446–450CrossRef PubMed
  25.Wildemann B, Schmidmaier G, Ordel S, Stange R, Haas NP, Raschke M (2003) Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers, PCNA and BrdU. J Biomed Mater Res B Appl Biomater 65(1):150–156CrossRef PubMed
  26.Yamada Y, Miyauchi A, Takagi Y, Nakauchi K, Miki N, Mizuno M, Harada A (2000) Association of a polymorphism of the transforming growth factor beta-1 gene with prevalent vertebral fractures in Japanese women. Am J Med 109(3):244–247CrossRef PubMed
  27.Utennam D, Tungtrongchitr A, Phonrat B, Tungtrongchitr R, Preutthipan S (2012) Association of T869C gene polymorphism of transforming growth factor-beta1 with low protein levels and anthropometric indices in osteopenia/osteoporosis postmenopausal Thai women. Genet Mol Res 11(1):87–99CrossRef PubMed
  28.Yamada Y, Miyauchi A, Takagi Y, Tanaka M, Mizuno M, Harada A (2001) Association of the C-509–>T polymorphism, alone of in combination with the T869–>C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med (Berl) 79(2–3):149–156CrossRef
  29.Hubacek JA, Weichetova M, Bohuslavova R, Skodova Z, Stepan JJ, Adamkova V (2006) No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in Caucasian females. Endocr Regul 40(4):107–112PubMed
  30.Tural S, Alayli G, Kara N, Tander B, Bilgici A, Kuru O (2013) Association between osteoporosis and polymorphisms of the IL-10 and TGF-beta genes in Turkish postmenopausal women. Hum Immunol 74(9):1179–1183CrossRef PubMed
  31.El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26(10):2205–2209PubMed
  32.Xing D, Ma XL, Ma JX, Xu WG, Wang J, Yang Y, Chen Y, Ma BY, Zhu SW (2013) Association between aspartic acid repeat polymorphism of the asporin gene and susceptibility to knee osteoarthritis: a genetic meta-analysis. Osteoarthritis Cartilage 21(11):1700–1706CrossRef PubMed
  33.da Costa AG, Gago MF, Garrett C (2011) Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson’s disease. Acta Med Port 24(Suppl 4):761–768PubMed
  34.Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31(29):3805–3820CrossRef PubMed PubMedCentral
  35.Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295(6):676–680CrossRef PubMed
  36.Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21(18):3672–3673CrossRef PubMed
  37.Kolundzic R, Trkulja V, Mikolaucic M, Kolundzic MJ, Pavelic SK, Pavelic K (2011) Association of interleukin-6 and transforming growth factor-beta1 gene polymorphisms with developmental hip dysplasia and severe adult hip osteoarthritis: a preliminary study. Cytokine 54(2):125–128CrossRef PubMed
  38.Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2003) Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32(3):297–310CrossRef PubMed
  39.Lau EM, Wong SY, Li M, Ma CH, Lim PL, Woo J (2004) Osteoporosis and transforming growth factor-beta-1 gene polymorphism in Chinese men and women. J Bone Miner Metab 22(2):148–152CrossRef PubMed
  40.Yamada Y, Okuizumi H, Miyauchi A, Takagi Y, Ikeda K, Harada A (2000) Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 43(2):452–460CrossRef PubMed
  41.Andonegui G, Ni A, Leger C, Kelly MM, Wong JF, Jalloul A, Winston BW (2012) Sequential expression of IGF-IB followed by active TGF-beta1 induces synergistic pulmonary fibroproliferation in vivo. Am J Physiol Lung Cell Mol Physiol 303(9):L788–L798CrossRef PubMed PubMedCentral
  42.Chen G, Ghosh P, O'Farrell T, Munk R, Rezanka LJ, Sasaki CY, Longo DL (2012) Transforming growth factor beta1 (TGF-beta1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53. J Biol Chem 287(27):23184–23195CrossRef PubMed PubMedCentral
  43.Imai K, Minamiya Y, Goto A, Nanjo H, Saito H, Motoyama S, Sato Y, Kudo S, Takashima S, Kawaharada Y, Kurihara N, Orino K, Ogawa J (2013) Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-beta1. World J Surg Oncol 11:113CrossRef PubMed PubMedCentral
  44.Zingariello M, Martelli F, Ciaffoni F, Masiello F, Ghinassi B, D'Amore E, Massa M, Barosi G, Sancillo L, Li X, Goldberg JD, Rana RA, Migliaccio AR (2013) Characterization of the TGF-beta1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood 121(17):3345–3363CrossRef PubMed PubMedCentral
  45.Liberek A, Kmiec Z, Kartanowicz D, Wierzbicki PM, Stanislawowski M, Kaszubowska L, Luczak G, Gora-Gebka M, Landowski P, Szlagatys-Sidorkiewicz A, Liberek T, Kaminska B, Jakobkiewicz-Banecka J, Wegrzyn G (2013) The mRNA level of the transforming growth factor beta1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. Int J Colorectal Dis 28(2):165–172CrossRef PubMed PubMedCentral
  46.Mukherjee A, Larson EA, Carlos AS, Belknap JK, Rotwein P, Klein RF (2012) Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor beta1-mediated signaling and bone acquisition. J Bone Miner Res 27(6):1345–1356CrossRef PubMed PubMedCentral
  47.Lau HH, Ho AY, Luk KD, Kung AW (2004) Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women. Calcif Tissue Int 74(6):516–521CrossRef PubMed
  48.Yamada Y (2000) Association of a Leu(10)–>Pro polymorphism of the transforming growth factor-beta1 with genetic susceptibility to osteoporosis and spinal osteoarthritis. Mech Ageing Dev 116(2–3):113–123CrossRef PubMed
  
• 作者单位：Yu Cong (1)
  Jiang-Ying Ru (2)
  Ni-Rong Bao (1)
  Ting Guo (1)
  Jian-Ning Zhao (1)
  
  1. Department of Orthopedics, Jinling Hospital, School of Medicine, Nanjing University, Zhongshan East Road, No. 305, Nanjing, 210002, People’s Republic of China
  2. Department of Orthopedics, Jiangsu Provincial Corps Hospital of the Chinese People’ Armed Police Force, Yangzhou, 225003, People’s Republic of China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  
• 出版者：Springer London
• ISSN：1434-9949

文摘

Genetic factors have been shown to be of great importance for the pathogenesis of bone diseases, such as fracture, osteoporosis (OP), and osteoarthritis (OA). However, published studies on the correlations of transforming growth factor-β1 (TGF-β1) gene polymorphisms with bone diseases have been hampered by small sample sizes or inconclusive findings. We hence aimed at examining the relationships between a single nucleotide polymorphism in the TGF-β1 gene (rs1982073 C>T) with bone fracture, OP, and OA risks in this meta-analysis. A systematic electronic search of literature was conducted to identify all published studies in English or Chinese on the association between the TGF-β1 gene and fracture, OP, or OA risks. Data were abstracted independently by two reviewers. To investigate the strength of this relationship, crude odds ratios with 95 % confidence intervals were used. An updated meta-analysis based on nine independent case–control studies were chosen (patients with fracture, OP, or OA = 1569; healthy controls = 1638). Results identified a higher frequency of rs1982073 C>T in patients with fracture, OP, or OA than in healthy controls. Ethnicity and genotyping method-stratified analysis under both models implied that the rs1982073 C>T polymorphism was positively correlated with the risk of fracture, OP, and OA among Asians under detection via the non-PCR-RFLP method. Disease-stratified results yielded that rs1982073 C>T may increase the risk of fracture, OP, and OA under the allele model, but was only significantly related to OP under the dominant model. According to the sample size-stratified analysis, subjects with the rs1982073 C>T polymorphism in the allele model were more likely to develop the three bone diseases in both the small and large sample size groups, and only in the large sample size under the dominant model. Our findings show that TGF-β1 rs1982073 C>T has a modest effect in increasing susceptibility to bone fracture, OP, and OA.